(Q36106858)

12 August 2017

1 reference

title

Utilizing combination therapy in the treatment of Alzheimer's disease (English)

1 reference

12 August 2017

0 references

Martin R Farlow

1

1 reference

12 August 2017

1 September 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

5

1 reference

12 August 2017

799-808

1 reference

Another advertisement for donepezil

12 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

The role of excitotoxicity in neurodegenerative disease: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Anti-inflammatory drugs in the fight against Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.799

21 January 2018

Identifiers

DOI

10.1586/14737175.4.5.799

1 reference

12 August 2017

1 reference

PubMed ID

15853507